VIVO
Meridian Bioscience Inc#40 · 2022BreakoutCYearly return
+61%
Peak return
+66%
Max drawdown
-18%
ADR (20 days)
+0.9%
Base
19 days / -11.6%
Prior run
+29%
Breakout volume
1.9x
Pivot
$22.14
Catalyst Earnings/Guidance2022-02-04Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare VIVO with the current market directly.